RoboCT showcased a comprehensive vision for human mobility that goes well beyond individual products. The Chinese exoskeleton leader outlined a strategic plan to create a full-lifecycle mobility ecosystem, centered on its innovative Rehabilitation-as-a-Service model and a broader concept of exoskeletons functioning as augmentative human “new organs.”
Health Technology Insights: Adagio Medical Adds Executives to Boost ULTC Launch
Dr. WANG Tian, Founder and CEO of RoboCT, explained that the company is shifting from being a specialized medical device manufacturer to a full-scale provider of human mobility solutions across different stages of life and daily scenarios. He emphasized that CES highlights more than the GoGo product line, presenting an integrated system where hardware, data, and professional services work together to provide continuous, personalized support from hospital care to at-home rehabilitation.
The foundation of this ecosystem is RoboCT’s Rehabilitation-as-a-Service model, which connects exoskeleton devices to a cloud-based intelligence platform. This enables real-time monitoring, remote therapist supervision, and customized training programs that adjust to individual needs. By extending professional-grade rehabilitation beyond the clinic, the platform improves accessibility and enhances recovery outcomes for users in both home and community settings.
Health Technology Insights: Connecticut HIE Adopts PIQXL Gateway to Boost Data Quality
RoboCT’s expansion builds on a strong track record. Its medical-grade exoskeletons were among the first in China to receive NMPA certification for neurological rehabilitation. The company holds over 500 patents and has helped establish multiple national and industry standards for exoskeleton robots. Its new manufacturing facility in Wuxi is designed to scale production for consumer-focused products like the GoGo series, delivering high performance at affordable costs.
Looking ahead, RoboCT has outlined a “Human+” vision, exploring applications beyond traditional healthcare. These include industrial support to prevent workplace injuries, wellness solutions for aging populations, and enhancements for outdoor activities. The company aims for exoskeleton technology to become a seamless and intuitive extension of the human body, improving strength, endurance, and mobility with minimal risk.
By presenting this ecosystem at CES, RoboCT positions itself as a pioneer in the evolving exoskeleton industry. The company is emphasizing that its mission is not only to sell devices but to create a future where robotic assistance is integrated into everyday life, boosting quality of life, productivity, and human potential worldwide.
Health Technology Insights: ACCO Brands to Acquire EPOS
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
